Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 416
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06043427 | Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Postive Advanced Gastroesophageal Adenocarcinoma | ||
| NCT00079053 | Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck | ||
| NCT00079066 | Cetuximab + Best Supportive Care Compared With Best Supportive Care Alone in Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer | ||
| NCT05300711 | Preventing Ovarian Cancer Through Oportunistic Salpingectomy at the Time of Colorectal Surgery | ||
| NCT03059199 | HAT TRICK: An Innovative Health Promotion Program for Men | ||
| NCT02750826 | Breast Cancer WEight Loss Study (BWEL Study) | ||
| NCT01982786 | Feasibility Trial Of Image Guided External Beam Radiotherapy With Or Without High Dose Rate Brachytherapy Boost In Men With Intermediate-Risk Prostate Cancer | ||
| NCT02784171 | Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma | ||
| NCT01419886 | Testing of a New Scale Measuring Medical Outcomes of Dysphagia (MOD) in Adult Patients With Swallowing Disorders | ||
| NCT00993655 | Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer | ||
| NCT03031821 | Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndrome | ||
| NCT02660788 | A Randomized Trial of Letters From Family Physicians to Encourage Screening Mammography in Overdue Women | ||
| NCT01624051 | A Study Comparing Chemotherapy Dosing Based on Either Standard Body Surface Area or Lean Body Mass in Patients With Advanced Lung Cancer | ||
| NCT06630273 | Canadian Initiative to Measure, Predict and Assess Cancer Treatment Outcomes in Patients Treated With Immuno-Oncotherapeutics | ||
| NCT05451004 | SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer | ||
| NCT02936258 | PRostate Evaluation for Clinically Important Disease: MRI vs Standard Evaluation Procedures | ||
| NCT01138384 | Study of Foretinib in Combination With Lapatinib in Patients With Metastatic Breast Cancer | ||
| NCT00014222 | Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer | ||
| NCT00305812 | Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma | ||
| NCT05576831 | STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision | ||
| NCT02628366 | Major Outcomes With Personalized Dialysate TEMPerature | ||
| NCT04136353 | Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate | ||
| NCT01355185 | Seed Movement in Prostate Brachytherapy Implants: Clinical Measurement and Dosimetric Consequences | ||
| NCT00017004 | Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia | ||
| NCT03410615 | Cisplatin + Radiotherapy vs Durvalumab + Radiotherapy Followed by Durvalumab vs Durvalumab + Radiotherapy Followed by Tremelimumab + Durvalumab in Intermediate-Risk HPV-Positive Oropharyngeal SCC | ||
| NCT01112384 | A Study of SB939 in Patients With Translocation-Associated Recurrent/Metastatic Sarcomas | ||
| NCT00377052 | Bortezomib and Gemcitabine in Treating Patients With Relapsed Mantle Cell Lymphoma | ||
| NCT00003890 | MG98 in Treating Patients With Advanced Solid Tumors | ||
| NCT00006890 | Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma | ||
| NCT01591421 | P13Kinase Inhibitor BKM120 in Combination With Panitumumab in Metastatic/Advanced RAS-Wild Type Colorectal Cancer. | ||
| NCT00030875 | Bortezomib in Treating Patients With Mantle Cell Lymphoma | ||
| NCT00238316 | Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density | ||
| NCT02960087 | Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer | ||
| NCT06193369 | Digital Peer Navigation for Adolescents and Young Adults With Cancer | ||
| NCT02861703 | Pilot Feasibility Study of an Online Lifestyle Intervention for Overweight Breast Cancer Survivors | ||
| NCT02273375 | Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC | ||
| NCT00003372 | Topotecan in Treating Patients With Recurrent Brain Tumors | ||
| NCT03259035 | NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer | ||
| NCT00095992 | SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer | ||
| NCT01948752 | Clinical Trial of Menu Labeling | ||
| NCT02285816 | MG1 Maraba/MAGE-A3, With and Without Adenovirus Vaccine With Transgenic MAGE-A3 Insertion in Incurable MAGE-A3-Expressing Solid Tumours | ||
| NCT03548077 | POWERPLAY: Promoting Men's Health at Work | ||
| NCT02272712 | The Effectiveness of Online Treatment for Insomnia in Cancer Survivors | ||
| NCT02870920 | Durvalumab and Tremelimumab and Best Supportive Care vs Best Supportive Care in Patients With Advanced Colorectal Cancer | ||
| NCT02649686 | Durvalumab in Patients With HER-2 Positive Metastatic Breast Cancer Receiving Trastuzumab | ||
| NCT04161248 | Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma | ||
| NCT00493376 | Study of Tumour Response to Tirapazamine During Treatment of Cervical Cancer | ||
| NCT02637024 | Trial of Radiation Fractionation Schedules for Once-a-Day Accelerated Partial Breast Irradiation | ||
| NCT00193882 | Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia. | ||
| NCT02537418 | Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy Regimens |
